Comments on the article: 'Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation'- Response to Pan et al

Br J Haematol. 2019 Mar;184(5):882-883. doi: 10.1111/bjh.15193. Epub 2018 Apr 20.
No abstract available

Keywords: CAR-T; Glucocorticoid; chimerism; donor-derived chimeric antigen receptor-modified T cells.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antigens, CD19
  • B-Lymphocytes
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunotherapy, Adoptive
  • Neoplasm, Residual
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma*
  • T-Lymphocytes / immunology

Substances

  • Antigens, CD19